🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending
Discoveries/NINTEDANIB
✓ X-VAULT VERIFIEDPRIORITY SIGNALNOVELTY: EXCEPTIONAL

NINTEDANIB

Neuronal System candidate

163341.9
discovery score
PubMed Studies
0
Novelty
Exceptional
Tier
Priority Signal
Sealed
Mar 8, 2026
BiohacksAI Hypothesis

Nintedanib may modulate the Neuronal System pathway based on its molecular target profile in the BiohacksAI corpus. This compound shows biological activity against validated targets with limited prior literature coverage, suggesting an understudied mechanism-of-action with potential research value.

This is a computational hypothesis based on target graph analysis. Not a confirmed mechanism. Independent experimental validation required.

Mechanism Discovery Graph
Neuronal SystemPotassium ChannelsVoltage gated Potas…Muscle contractionPhase 3 - rapid rep…Cardiac conductionKCNH2ABCB1FLT3ABL1KDRLCKRETSRCNINTEDANI
High-value target (Tier 3)
Research target (Tier 2)
Standard target
Pathway
Knowledge gap (≤5 studies)
Biological Plausibility

The Neuronal System pathway is a validated biological target area with established relevance in human disease and health optimization research.

Nintedanib shows target overlap with compounds previously characterized in this pathway within the BiohacksAI corpus of 9,238 graph entities and 1.12M PubMed studies.

Low literature coverage (0 studies) relative to target engagement indicates this mechanism may be undercharacterized in current scientific literature — a signal consistent with early-stage discovery candidates.

Novelty Indicators
Literature coverage
0 PubMed studies
Low coverage = higher novelty potential
Discovery score
163341.93
target_count × pathway_diversity / log(studies + 2)
Mechanism area
Neuronal System
Primary biological pathway
Novelty rating
Exceptional
Derived from score + literature coverage
Research Context
◈
Literature coverage
0 PubMed studies indexed at time of discovery
◈
X-Vault timestamp
Sealed Mar 8, 2026 — cryptographic proof of discovery date and corpus version
◈
Corpus scope
BiohacksAI corpus only — not a comprehensive literature or patent database search
◈
Mechanism area
Neuronal System — computationally derived, requires experimental confirmation

This section reflects computational signal strength only. BiohacksAI does not perform patent searches or legal IP analysis. All findings require independent expert validation before any commercial or research use.

Suggested Validation Steps
1Neuronal System pathway target binding assay
2Dose-response curve (EC50 determination)
3Cellular viability and selectivity panel
4In vitro ADMET profiling

Validation roadmap is algorithmically derived from pathway context. Full experimental protocol available in Priority Signal discovery reports.

Discovery Lineage
Generated byBiohacksAI Discovery Engine
Engine versionDISCOVERY_v1.0
Corpus versionv20260307-01
Graph entities9,238 compounds analyzed
PubMed coverage1,120,000+ studies
Discovery dateMarch 8, 2026 at 01:00 PM UTC
X-Vault Evidence SealXVAULT_v1
Discovery IDDISC-nintedanib-20260308-d312809f
Event Hasha7431f0723f8cfdb…661d7329
Chain Hash2d3257be42244974…7730e50e
Vault Index#10
Sealed At2026-03-08T13:00:35.148Z
Verify this discovery →eveverified.com/verify
Full Discovery ReportLOCKED
🔒
Mechanism hypothesis (expanded)
Detailed molecular mechanism with target confidence scores and binding context
🔒
Complete target mapping
All validated molecular targets with affinity data and evidence levels
🔒
Biological pathway network
Full pathway coverage map with crosstalk and downstream effects
🔒
Graph position + related compounds
Structural neighbors in the BiohacksAI compound graph — potential analogs
🔒
Supporting PMIDs
Curated PubMed references with relevance ranking
🔒
X-Vault sealed PDF
Cryptographically verified 20-30 page discovery report
🔒
Signed license agreement
Legal document with IP terms, royalty clause, and X-Vault seal reference

Purchase License

Unlocks full discovery report, PDF, and signed license agreement within 24 hours.

SHARED RESEARCH LICENSE
$999
  • ✓ Full discovery report PDF
  • ✓ X-Vault seal + verification link
  • ✓ Research & publication rights
  • ✓ 10% royalty share if IP is commercialised
  • BiohacksAI retains 90% IP · Multiple buyers
Purchase Shared License — $999
EXCLUSIVE LICENSE
$24,900
  • ✓ Everything in Shared
  • ✓ Commercial rights
  • ✓ One buyer — exclusivity guaranteed
  • ✓ 90% IP transferred to buyer
  • BiohacksAI retains 10% royalty on commercialisation
Purchase Exclusive License — $24,900

All discoveries are computational hypothesis candidates — not confirmed mechanisms. Patent eligibility must be independently assessed by qualified counsel. X-Vault seals provide cryptographic proof of discovery timestamp and corpus version. Organiq Sweden AB · BiohacksAI β